Skip to search formSkip to main contentSkip to account menu

Folotyn

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
the peripheral t-cell lymphomas (ptCLs) are a diverse group of mature t-cell neoplasms that typically display aggressive clinical… 
Review
2012
Review
2012
T-cell lymphoma accounts for 10% to 15% of all cases of non-Hodgkin lymphoma in the United States (approximately 5000 to 6000… 
Review
2011
Review
2011
Abstract 4745 Mucositis is a frequent complication experienced by patients receiving weekly Pralatrexate, an antifolate agent… 
2010
2010
New molecular entity: Pralatrexate injection (Folotyn) was approved on September 24, 2009, for the treatment of patients with… 
2010
2010
8054 Background: Pralatrexate (FOLOTYN) is a targeted antifolate designed for preferential uptake and accumulation in tumor cells…